(NASDAQ: LSTA) Lisata Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.93%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 36.19%.
Lisata Therapeutics's earnings in 2026 is -$16,586,000.On average, 4 Wall Street analysts forecast LSTA's earnings for 2026 to be -$8,844,419, with the lowest LSTA earnings forecast at -$8,497,579, and the highest LSTA earnings forecast at -$9,104,549. On average, 4 Wall Street analysts forecast LSTA's earnings for 2027 to be -$6,080,538, with the lowest LSTA earnings forecast at -$5,842,086, and the highest LSTA earnings forecast at -$6,259,378.
In 2028, LSTA is forecast to generate -$9,028,678 in earnings, with the lowest earnings forecast at -$8,674,612 and the highest earnings forecast at -$9,294,227.